Item
Vitamin B2 (Riboflavin) (1131)
Riboflavin-98-102% and water, ash NMT-1.8%
Nutrient / Vitamin
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Hubei Guangji Pharmaceutical Co., Ltd | Dajin Guangji Pharm Bio-Industrial Park Wuxue City, Huanggang, HB 435400 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| HARPC Food Safety Plan (Item) | Hubei Guangji Pharmaceutical Co., Ltd | 3rd party-Haccp doc - Prinova.pdf | 1/1/2023 | 1/1/2026 |
| HACCP | Hubei Guangji Pharmaceutical Co., Ltd | 3rd party-Haccp doc - Prinova.pdf | 4/11/2023 | 4/10/2026 |
| Gluten | Hubei Guangji Pharmaceutical Co., Ltd | Allergen - 2025-04-25T161138.496.pdf | 4/25/2025 | 4/25/2027 |
| Allergens EU/UK | Hubei Guangji Pharmaceutical Co., Ltd | Allergens EU/UK.pdf | 11/19/2024 | 11/19/2026 |
| Allergens | Hubei Guangji Pharmaceutical Co., Ltd | Allergens.pdf | 11/13/2023 | 11/12/2025 |
| CoA Sample | Hubei Guangji Pharmaceutical Co., Ltd | Approved COA Template - 2025-03-19T132522.051.pdf | 3/19/2025 | 3/19/2027 |
| WADA/NSF/NFL Statement | Hubei Guangji Pharmaceutical Co., Ltd | Banned Substance (76).pdf | 3/2/2023 | 3/1/2025 |
| Pesticide | Hubei Guangji Pharmaceutical Co., Ltd | Contaminants and Impurities - 2023-07-03T134001.372.pdf | 3/2/2023 | 3/1/2025 |
| Heavy Metal | Hubei Guangji Pharmaceutical Co., Ltd | Contaminants and Impurities - 2024-03-13T101407.285.pdf | 2/3/2023 | 2/2/2025 |
| Residual Statement | Hubei Guangji Pharmaceutical Co., Ltd | Contaminants and Impurities - 2024-03-13T110108.522.pdf | 3/2/2024 | 3/2/2025 |
| Country of Origin EU/UK | Hubei Guangji Pharmaceutical Co., Ltd | Country of Origin EU/UK.pdf | 10/26/2022 | 10/25/2025 |
| Country of Origin | Hubei Guangji Pharmaceutical Co., Ltd | Country of Origin.pdf | 9/9/2024 | 9/9/2027 |
| No Animal Ingredient Statement | Hubei Guangji Pharmaceutical Co., Ltd | Dietary Status (52).pdf | 9/6/2023 | 9/5/2024 |
| Dietary Supplement Questionnaire | Hubei Guangji Pharmaceutical Co., Ltd | Dietary Supplement Questionnaire.pdf | 10/25/2019 | 10/24/2020 |
| GRAS/NDI/ODI Statement | Hubei Guangji Pharmaceutical Co., Ltd | FDA Regulatory Status Riboflavin.pdf | 1/20/2023 | 1/19/2026 |
| HACCP Process Flow Diagram | Hubei Guangji Pharmaceutical Co., Ltd | Flow Chart - 2023-06-21T150222.558.pdf | 3/2/2023 | 3/1/2025 |
| FSVP Assessment Form | Hubei Guangji Pharmaceutical Co., Ltd | FSVP Assessment Form.pdf | 5/29/2024 | 5/29/2025 |
| GMO | Hubei Guangji Pharmaceutical Co., Ltd | GMO - 2023-06-21T150846.780.pdf | 3/2/2023 | 3/1/2025 |
| Halal | Hubei Guangji Pharmaceutical Co., Ltd | Halal Certificate - 2025-04-25T144130.472.pdf | 12/1/2021 | 11/30/2025 |
| Item Questionnaire | Hubei Guangji Pharmaceutical Co., Ltd | Item Questionnaire.pdf | 1/29/2025 | 1/29/2028 |
| Kosher | Hubei Guangji Pharmaceutical Co., Ltd | Kosher Certificate - 2025-04-02T152144.007.pdf | 3/13/2025 | 3/31/2026 |
| National Bioengineered Food Disclosure Standard (Simplified) | Hubei Guangji Pharmaceutical Co., Ltd | National Bioengineered Food Disclosure Standard (Simplified).pdf | 3/13/2024 | 3/13/2027 |
| Sewage Statement | Hubei Guangji Pharmaceutical Co., Ltd | Natural Status.pdf | 7/24/2023 | 7/23/2025 |
| Nutrition | Hubei Guangji Pharmaceutical Co., Ltd | Nutrition.pdf | 7/25/2023 | 7/24/2026 |
| Lot Code | Hubei Guangji Pharmaceutical Co., Ltd | Packaging Declaration - 2023-06-21T145536.619.pdf | 3/2/2023 | 3/1/2026 |
| Label Sample | Hubei Guangji Pharmaceutical Co., Ltd | Packaging Declaration - 2025-03-03T154210.336.pdf | 3/3/2025 | 3/3/2026 |
| Food Contact Packaging Certificate of Compliance | Hubei Guangji Pharmaceutical Co., Ltd | Packaging Declaration - 2025-05-27T103037.785.pdf | 5/27/2025 | 5/27/2027 |
| California Prop. 65 | Hubei Guangji Pharmaceutical Co., Ltd | Product Data Sheet - 2025-01-07T105754.137.pdf | 3/2/2024 | 3/2/2026 |
| Ingredient Statement | Hubei Guangji Pharmaceutical Co., Ltd | Product Data Sheet - 2025-04-04T160321.072.pdf | 4/4/2025 | 4/3/2028 |
| Irradiation Status Statement | Hubei Guangji Pharmaceutical Co., Ltd | Production Process (100).pdf | 4/25/2025 | 4/25/2027 |
| Label Claims | Hubei Guangji Pharmaceutical Co., Ltd | Regulatory Information Sheet - 2023-07-03T134155.452.pdf | 3/2/2023 | 3/2/2026 |
| Organic | Hubei Guangji Pharmaceutical Co., Ltd | Regulatory Information Sheet - 2023-07-03T134155.452.pdf | 3/2/2023 | 3/2/2026 |
| BSE - TSE | Hubei Guangji Pharmaceutical Co., Ltd | Regulatory Information Sheet - 2023-07-14T144031.327.pdf | 3/2/2023 | 3/1/2026 |
| Animal Testing Statement | Hubei Guangji Pharmaceutical Co., Ltd | Regulatory Information Sheet - 2025-04-25T153543.576.pdf | 4/25/2025 | 4/25/2027 |
| Vegan/Vegetarian Statement | Hubei Guangji Pharmaceutical Co., Ltd | Regulatory Information Sheet - 2025-04-25T160217.490.pdf | 4/25/2025 | 4/25/2027 |
| Safety Data Sheet (SDS) | Hubei Guangji Pharmaceutical Co., Ltd | SDS - 2024-09-23T094155.652.pdf | 3/2/2023 | 3/1/2026 |
| Shelf Life | Hubei Guangji Pharmaceutical Co., Ltd | Specification - Factory - 2025-01-08T154728.445.pdf | 9/20/2024 | 9/20/2027 |
| Product Specification Sheet | Hubei Guangji Pharmaceutical Co., Ltd | Specification - Factory (83).pdf | 9/26/2023 | 9/25/2026 |
| Suitability Requirements | Hubei Guangji Pharmaceutical Co., Ltd | Suitability Requirements.pdf | 8/1/2023 | 7/31/2026 |
